Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk


Report at a Glance

  • Brochure- When to Share Data (Printable)” (PDF)
  • Brochure- When to Share Data (Web Version) (PDF)
  • Complete Recommendations (PDF)
  • Infographic (HTML)
  • Key Figures (PDF)
  • Report Brief (PDF)
  • Public Release Slides - Handout Format (PDF)
  • Public Release Slides - Presentation Format (PDF)
  • State of the Field: Governance, Technical Infrastructure, and Sustainability (PDF)

Download an introductory slide for this report >>

Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical care by maximizing the knowl­edge gained from data collected in trials, stimulating new ideas for research, and avoiding unnecessarily duplicative trials. In response to 23 public- and private-sector sponsors in the United States and abroad, the Institute of Medicine (IOM) assembled a committee to develop guiding principles and a practical framework for the responsible sharing of clinical trial data. In its report, Sharing Clinical Trial Data: Maxi­mizing Benefits, Minimizing Risk, the committee concludes that sharing data is in the public interest, but a multi-stakeholder effort is needed to develop a culture, infrastructure, and policies that will foster responsible sharing—now and in the future.